In last trading session, Zosano Pharma Corporation (NASDAQ:ZSAN) saw 8,033,835 shares changing hands with its beta currently measuring 3.96. Company’s recent per share price level of $0.94 trading at $0.02 or 3.09% at ring of the bell on the day assigns it a market valuation of $96.36 Million. That closing price of ZSAN’s stock is at a discount of -108.51% from its 52-week high price of $1.96 and is indicating a premium of 65.11% from its 52-week low price of $0.328. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 19Million shares which gives us an average trading volume of 5.8 Million if we extend that period to 3-months.
For Zosano Pharma Corporation (ZSAN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.7. Splitting up the data highlights that, out of 3 analysts covering the stock, none rated the stock as a Sell while none recommended an Overweight rating for the stock. None suggested the stock as a Hold whereas 3 see the stock as a Buy. None analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.09 in the current quarter.
Zosano Pharma Corporation (NASDAQ:ZSAN) trade information
Upright in the green during last session for gaining 3.09%, in the last five days ZSAN remained trading in the green while hitting it’s week-highest on Wednesday, Jan 13 when the stock touched $0.998 price level, adding 5.4% to its value on the day. Zosano Pharma Corporation’s shares saw a change of 79.11% in year-to-date performance and have moved 19.31% in past 5-day. Zosano Pharma Corporation (NASDAQ:ZSAN) showed a performance of 46.44% in past 30-days. Number of shares sold short was 6.84 Million shares which calculate 1.18 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of $1.83 to the stock, which implies a rise of 94.68% to its current value. Analysts have been projecting $1.5 as a low price target for the stock while placing it at a high target of $2. It follows that stock’s current price would jump +112.77% in reaching the projected high whereas dropping to the targeted low would mean a loss of 59.57% for stock’s current value.
Zosano Pharma Corporation (ZSAN) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 47.1% during past 5 years. In 2021, company’s earnings growth rate is likely to be around 38.7% while estimates for its earnings growth in next 5 years are of 0%
Zosano Pharma Corporation (NASDAQ:ZSAN)’s Major holders
Insiders are in possession of 0.36% of company’s total shares while institution are holding 15.59% percent of that, with stock having share float percentage of 15.65%. Investors also watch the number of corporate investors in a company very closely, which is 46 institutions for Zosano Pharma Corporation that are currently holding shares of the company. Vanguard Group, Inc. (The) is the top institutional holder at ZSAN for having 3.18 Million shares of worth $5.16 Million. And as of September 29, 2020, it was holding 4.64% of the company’s outstanding shares.
The second largest institutional holder is Aisling Capital Management LP, which was holding about 2.72 Million shares on September 29, 2020. The number of shares represents firm’s hold over 3.96% of outstanding shares, having a total worth of $4.4 Million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of September 29, 2020, the former fund manager was holding 2386187 shares of worth $3.87 Million or 3.48% of the total outstanding shares. The later fund manager was in possession of 651.22 Thousand shares on September 29, 2020, making its stake of worth around $1.05 Million in the company or a holder of 0.95% of company’s stock.
Even if you’re not actively in crypto, you deserve to know what’s actually going on..
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets are already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.